Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 481 - 490 of 495 results

First page
Previous page
49
Next page
Next page

DEFIBROTIDE SODIUM

L7CHH2B2J0

Status:

US Approved Rx (2016)

Source:

NDA208114

(2016)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208114

First approved in 2016

Source:

NDA208114

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208114

Class:

POLYMER

POLYQUATERNIUM-6 (15000 MW)

YFL33X52PX

Status:

Possibly Marketed Outside US

Source:

21 CFR 358H

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d42d3eb-3cb6-39d3-e054-00144ff8d46c

First approved in 2016

Source:

21 CFR 358H

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d42d3eb-3cb6-39d3-e054-00144ff8d46c

Class:

POLYMER

INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)

5UFQ6ZRS6Y

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb8f92de-56eb-41e3-b3f8-f1b9911e3c40

First approved in 2016

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb8f92de-56eb-41e3-b3f8-f1b9911e3c40

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

N4UXA9H8KA

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb8f92de-56eb-41e3-b3f8-f1b9911e3c40

First approved in 2016

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb8f92de-56eb-41e3-b3f8-f1b9911e3c40

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Z5EJE3EP8T

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

0QK4U2V88L

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84452700-6f7b-4eec-af36-ee2e0f52f7f0

First approved in 2016

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84452700-6f7b-4eec-af36-ee2e0f52f7f0

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Z6Y9Y35SOY

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

Class:

STRUCTURALLY DIVERSE

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

AL8G7D406D

Status:

Possibly Marketed Outside US

Source:

BLA125254

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84452700-6f7b-4eec-af36-ee2e0f52f7f0

First approved in 2016

Source:

BLA125254

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84452700-6f7b-4eec-af36-ee2e0f52f7f0

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

CA1YT4NE3M

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

Class:

STRUCTURALLY DIVERSE

INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

G4VX46P9M6

Status:

Possibly Marketed Outside US

Source:

BLA125408

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

First approved in 2016

Source:

BLA125408

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40406cf8-a2ae-4159-a8a5-5d02e5c6c7bc

Class:

STRUCTURALLY DIVERSE

Structure of DEFIBROTIDE SODIUM

Polymer

DEFIBROTIDE SODIUM

Structure of POLYQUATERNIUM-6 (15000 MW)

Polymer

POLYQUATERNIUM-6 (15000 MW)

Structurally Diverse

INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/DARWIN/6/2021 IVR-227 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/INDIANA/08/2018 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/IDAHO/07/2018 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/IOWA/06/2017 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Structurally Diverse

INFLUENZA B VIRUS B/SINGAPORE/INFTT-16-0610/2016 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)

Showing 481 - 490 of 495 results

First page
Previous page
49
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1